We shot the new Glock Gen 6. With many ergonomic upgrades and an improved optics mounting system it is the best out-of-the ...

The host of Firearms of America reminds viewers that Gaston Glock wasn’t a gun designer, or even in the firearms business. He ...

Ever wondered if Kohl's could be one of those overlooked stocks that's hiding serious value? You're definitely not alone in asking the question these days. Shares have jumped 48.3% in the last month ...

Dozens of drug companies raised prices at a higher rate than inflation and will need to pay rebates to Medicare, the U.S. Department of Health and Human Services announced Thursday. The refunds are ...

Shares of SBI Life Insurance Company gained another 4% in Thursday’s trade on November 20, hitting a fresh all-time high of ₹2,028 as they remained higher for the second consecutive session. The stock ...

XRP price trades near $2.15 today after dropping over 18% since November 10. The token has spent the past month moving inside a bearish channel. And the latest structure now shows weakening volume, ...

[SINGAPORE] A unit of Singtel’s wholly owned subsidiary Optus has priced S$200 million in 10-year fixed-rate notes due in 2035 at 2.48 per cent. The notes will be drawn down under Optus Finance’s Euro ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Irina is a writer for Oilprice.com with over a decade of experience writing on the oil and gas industry. U.S. sanctions on the global operations of Russian oil heavyweights Rosneft and Lukoil enter ...

Guggenheim raised the firm’s price target on Cybin (CYBN) to $48 from $39 and keeps a Buy rating on the shares. Noting that the company’s Phase 3 program for CYB003 in adjunctive MDD is advancing as ...